Digital Therapeutics (DTx) Market Worth $17.7 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In August 2022, Pear Therapeutics (US) entered into an agreement with SelectHealth (US) to provide members with covered access to Pear’s innovative prescription digital therapeutic (PDT), reSET-O, for treating opioid use disorder (OUD) as an adjunct to outpatient treatment.
View full press release